e-learning
resources
Madrid 2019
Saturday, 28.09.2019
PG1 Lung cancer: the key multidisciplinary approach
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives
T. Blum (Berlin, Germany)
Source:
International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Session:
PG1 Lung cancer: the key multidisciplinary approach
Session type:
Postgraduate Course
Number:
82
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Blum (Berlin, Germany). Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives. International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Year: 2006
The chest physician as the lung cancer patient’s guide: defining the role of the modern day chest physician throughout the lung cancer continuum
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Year: 2017
Lung cancer: clinical presentation and specialist referral time
Source: Eur Respir J 2004; 24: 898-904
Year: 2004
The role of bronchoscopy in the diagnosis of lung cancer: an audit to assess standards
Source: Eur Respir J 2001; 18: Suppl. 33, 62s
Year: 2001
Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing?
Source: Eur Respir J 2014; 44: 1011-1022
Year: 2014
Repeat diagnostic thoracocentesis in lung cancer staging – fiddling whilst Rome burns?
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007
Diagnostic yield, clinical impact and cost aspect of EBUS-TBNA in mediastinal staging in lung cancer
Source: Annual Congress 2012 - Progress in endoscopy for lung cancer
Year: 2012
Mediastinal staging in lung cancer: A rational approach
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010
Feasibility, yield and impact of ambulatory EBUS-TBNA for the diagnosis and staging of lung cancer
Source: Annual Congress 2007 - Bronchoscopic staging modalities in lung cancer
Year: 2007
Patient and procedure determinants of EBUS-TBNA accuracy in mediastinal staging of lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
PET-CT a useful staging tool for patients with non small lung cancer when applied based on surgeons‘ discretion as well as guidelines
Source: Annual Congress 2010 - State of the art imaging
Year: 2010
Is time from "referral to diagnosis" in lung cancer pathway affected by diagnostic test delays?
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
What the radiologist can offer - the latest imaging and evaluation techniques for lung cancer screening and comorbidities
Source: International Congress 2018 – Lung cancer screening and management of solitary pulmonary nodules
Year: 2018
The use of surgical services in the management of suspected lung cancers
Source: Annual Congress 2012 - Epidemiology and care research of lung cancer
Year: 2012
Modern staging in lung cancer: from the current multidisciplinary process to novel approaches
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019
New insights into lung cancer: what radiologists can contribute to diagnosis and staging
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept